249 related articles for article (PubMed ID: 23169485)
1. Immunoparesis and monoclonal gammopathy of undetermined significance are disassociated in advanced age.
Cherry BM; Costello R; Zingone A; Burris J; Korde N; Manasanch E; Kwok M; Annunziata C; Roschewski MJ; Engels EA; Landgren O
Am J Hematol; 2013 Feb; 88(2):89-92. PubMed ID: 23169485
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and progression of monoclonal gammopathy of undetermined significance and light-chain MGUS in Germany.
Eisele L; Dürig J; Hüttmann A; Dührsen U; Assert R; Bokhof B; Erbel R; Mann K; Jöckel KH; Moebus S;
Ann Hematol; 2012 Feb; 91(2):243-8. PubMed ID: 21789623
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a retrospective population-based cohort study.
Dispenzieri A; Katzmann JA; Kyle RA; Larson DR; Melton LJ; Colby CL; Therneau TM; Clark R; Kumar SK; Bradwell A; Fonseca R; Jelinek DF; Rajkumar SV
Lancet; 2010 May; 375(9727):1721-8. PubMed ID: 20472173
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of monoclonal gammopathy of undetermined significance in an elderly urban Korean population.
Park HK; Lee KR; Kim YJ; Cho HI; Eun Kim J; Woong Kim K; Jung Kim Y; Lee KW; Hyun Kim J; Bang SM; Lee JS
Am J Hematol; 2011 Sep; 86(9):752-5. PubMed ID: 21786289
[TBL] [Abstract][Full Text] [Related]
5. Multiple Myeloma and Its Precursor Disease Among Firefighters Exposed to the World Trade Center Disaster.
Landgren O; Zeig-Owens R; Giricz O; Goldfarb D; Murata K; Thoren K; Ramanathan L; Hultcrantz M; Dogan A; Nwankwo G; Steidl U; Pradhan K; Hall CB; Cohen HW; Jaber N; Schwartz T; Crowley L; Crane M; Irby S; Webber MP; Verma A; Prezant DJ
JAMA Oncol; 2018 Jun; 4(6):821-827. PubMed ID: 29710195
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal Gammopathy of Undetermined Significance (MGUS)Monoclonal Gammopathy of Undetermined Significance (MGUS).
Viera S; Ludek P; Zdeněk A; Marta K; Martin Š; Sabina Š; Zdeněk K
Klin Onkol; 2018; 31(4):270-276. PubMed ID: 30541309
[TBL] [Abstract][Full Text] [Related]
7. [Monoclonal gammopathy of undetermined significance and evolution to myeloma: Experience in 153 patients].
López Gómez JM; Sacristán Enciso B; Fernández-Cavada Pollo MJ; Bueno García V; Gómez Vera S
Semergen; 2021 Oct; 47(7):441-447. PubMed ID: 34479794
[TBL] [Abstract][Full Text] [Related]
8. [Analysis of serum levels of Dickkopf-1 (DKK-1) in monoclonal gammopathy of undetermined significance and multiple myeloma].
Ščudla V; Petrová P; Pika T; Lochman P; Minařík J; Bačovský J; Srovnalík K
Cas Lek Cesk; 2015; 154(4):181-8. PubMed ID: 26357861
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal gammopathy of undetermined significance and risk of lymphoid and myeloid malignancies: 728 cases followed up to 30 years in Sweden.
Turesson I; Kovalchik SA; Pfeiffer RM; Kristinsson SY; Goldin LR; Drayson MT; Landgren O
Blood; 2014 Jan; 123(3):338-45. PubMed ID: 24222331
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of monoclonal gammopathy of undetermined significance in Shenzhen, China.
Xu A; Guo T; Zhang S; Luo H; Shen M; Ye Y; Ji L
Hematology; 2024 Dec; 29(1):2352686. PubMed ID: 38819332
[TBL] [Abstract][Full Text] [Related]
11. Increased prevalence of light chain monoclonal gammopathy of undetermined significance (LC-MGUS) in first-degree relatives of individuals with multiple myeloma.
Greenberg AJ; Rajkumar SV; Larson DR; Dispenzieri A; Therneau TM; Colby CL; Phelps TK; Kumar SK; Katzmann JA; Kyle RA; Slager SL; Vachon CM
Br J Haematol; 2012 May; 157(4):472-5. PubMed ID: 22629552
[TBL] [Abstract][Full Text] [Related]
12. [The value of serum free light chain in differential diagnosis of monoclonal gammopathy of renal significance].
Li C; Wen YB; Li H; Su W; Li J; Cai JF; Chen LM; Li XM; Li XW
Zhonghua Yi Xue Za Zhi; 2017 Aug; 97(30):2344-2348. PubMed ID: 28822451
[No Abstract] [Full Text] [Related]
13. Prognostic Impact of Serum Heavy/Light Chain Pairs in Patients With Monoclonal Gammopathy of Undetermined Significance and Smoldering Myeloma: Long-Term Results From a Single Institution.
Magnano L; Fernández de Larrea C; Elena M; Cibeira MT; Tovar N; Aróstegui JI; Pedrosa F; Rosiñol L; Filella X; Yagüe J; Bladé J
Clin Lymphoma Myeloma Leuk; 2016 Jun; 16(6):e71-7. PubMed ID: 27013181
[TBL] [Abstract][Full Text] [Related]
14. Long-term follow-up of patients with monoclonal gammopathy of undetermined significance after kidney transplantation.
Naina HV; Harris S; Dispenzieri A; Cosio FG; Habermann TM; Stegall MD; Dean PG; Prieto M; Kyle RA; Rajkumar SV; Leung N
Am J Nephrol; 2012; 35(4):365-71. PubMed ID: 22473253
[TBL] [Abstract][Full Text] [Related]
15. Comparative evaluation of involved free light chain and monoclonal spike as markers for progression from monoclonal gammopathy of undetermined significance to multiple myeloma.
Gran C; Liwing J; Wagner AK; Verhoek A; Gezin A; Alici E; Nahi H
Am J Hematol; 2021 Jan; 96(1):23-30. PubMed ID: 32936979
[TBL] [Abstract][Full Text] [Related]
16. Detection and prevalence of monoclonal gammopathy of undetermined significance: a study utilizing mass spectrometry-based monoclonal immunoglobulin rapid accurate mass measurement.
Murray D; Kumar SK; Kyle RA; Dispenzieri A; Dasari S; Larson DR; Vachon C; Cerhan JR; Rajkumar SV
Blood Cancer J; 2019 Dec; 9(12):102. PubMed ID: 31836698
[TBL] [Abstract][Full Text] [Related]
17. Light chain monoclonal gammopathy of undetermined significance is characterized by a high disappearance rate and low risk of progression on longitudinal analysis.
Pelzer BW; Arendt M; Moebus S; Eisele L; Jöckel KH; Dührsen U; Dürig J;
Ann Hematol; 2018 Aug; 97(8):1463-1469. PubMed ID: 29629484
[TBL] [Abstract][Full Text] [Related]
18. Characteristics and prognosis of patients with non-immunoglobulin-M monoclonal gammopathy of undetermined significance: a retrospective study.
Kuwabara C; Sakuma Y; Kume A; Tamura Y; Shimizu R; Iwai R; Ishii A; Tanaka H
Int J Hematol; 2019 Feb; 109(2):154-161. PubMed ID: 30406907
[TBL] [Abstract][Full Text] [Related]
19. Long-Term Follow-up of Monoclonal Gammopathy of Undetermined Significance.
Kyle RA; Larson DR; Therneau TM; Dispenzieri A; Kumar S; Cerhan JR; Rajkumar SV
N Engl J Med; 2018 Jan; 378(3):241-249. PubMed ID: 29342381
[TBL] [Abstract][Full Text] [Related]
20. Association of Immune Marker Changes With Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma.
Landgren O; Hofmann JN; McShane CM; Santo L; Hultcrantz M; Korde N; Mailankody S; Kazandjian D; Murata K; Thoren K; Ramanathan L; Dogan A; Rustad E; Lu SX; Akhlaghi T; Kristinsson SY; Björkholm M; Devlin S; Purdue MP; Pfeiffer RM; Turesson I
JAMA Oncol; 2019 Sep; 5(9):1293-1301. PubMed ID: 31318385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
